NasdaqGM:ARDXBiotechs
Ardelyx Brings In New Legal Chief As Governance Enters Next Phase
Ardelyx (NasdaqGM:ARDX) appointed Felecia W. Ettenberg as Chief Legal Officer, succeeding Elizabeth Grammer.
The transition follows Grammer’s 16 year tenure in the role.
Ettenberg brings extensive legal and regulatory experience from a leading pharmaceutical company.
Ardelyx focuses on therapies in the biopharmaceutical space, where regulatory scrutiny, patent protection, and compliance requirements shape how companies operate. A new Chief Legal Officer sits at the center of these issues,...